Cargando…
Anti-SARS-CoV-2 Immunoglobulin Isotypes, and Neutralization Activity Against Viral Variants, According to BNT162b2-Vaccination and Infection History
PURPOSE: To compare SARS-CoV-2 antigen-specific antibody production and plasma neutralizing capacity against B.1 wild-type-like strain, and Gamma/P.1 and Delta/B.1.617.2 variants-of-concern, in subjects with different Covid-19 disease and vaccination histories. METHODS: Adult subjects were: 1) Unvac...
Autores principales: | Tarkowski, Maciej, de Jager, Wilco, Schiuma, Marco, Covizzi, Alice, Lai, Alessia, Gabrieli, Arianna, Corbellino, Mario, Bergna, Annalisa, Ventura, Carla Della, Galli, Massimo, Riva, Agostino, Antinori, Spinello |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718396/ https://www.ncbi.nlm.nih.gov/pubmed/34975897 http://dx.doi.org/10.3389/fimmu.2021.793191 |
Ejemplares similares
-
Rapid lateral-flow immunochromatographic tests to assess anti N/S IgG seropositivity after BNT162b2 vaccine: A cross-sectional study: Rapid lateral-flow immunochromatographic tests after BNT162b2 vaccine.
por: Pezzati, Laura, et al.
Publicado: (2021) -
Immunogenicity of two doses of BNT162b2 and mRNA‐1273 vaccines for solid cancer patients on treatment with or without a previous SARS‐CoV‐2 infection
por: La Verde, Nicla, et al.
Publicado: (2022) -
Impact of prior infection status on antibody response to the BNT162b2 mRNA COVID-19 vaccine in healthcare workers at a COVID-19 referral hospital in Milan, Italy
por: Milazzo, Laura, et al.
Publicado: (2022) -
Definition of the Immune Parameters Related to COVID-19 Severity
por: Birindelli, Sarah, et al.
Publicado: (2022) -
Corrigendum: Definition of the immune parameters related to COVID-19 severity
por: Birindelli, Sarah, et al.
Publicado: (2023)